97 Odcinki

  1. Episode 57 – Drug Pricing: What Trends Emerged from the 2023 Medicaid Drug Rebate Program Summit?

    Opublikowany: 20.10.2023

  2. Episode 56 – M&A Views: Avoiding Buyer’s Remorse in M&A Deals

    Opublikowany: 27.09.2023

  3. Episode 55 – Insurtech: What Should Startups Do After Receiving FCA Authorization?

    Opublikowany: 21.09.2023

  4. Episode 54 – Drug Pricing: Focus on Best Price — CMS Proposed Rule, Inflation Reduction Act

    Opublikowany: 15.09.2023

  5. Episode 53 – Energy & Infrastructure: Can Sustainable Finance Fuel the Energy Transition?

    Opublikowany: 30.08.2023

  6. Episode 52 – Drug Pricing: Could a Single Reference Price Apply Across a Therapeutic Class?

    Opublikowany: 21.08.2023

  7. Episode 51 – Drug Pricing: Final IRA Price Negotiation Guidance – How CMS Addressed the Part D/B Problem

    Opublikowany: 31.07.2023

  8. Episode 50 – PE Views: Under New Reforms, Is the Customer Always Right?

    Opublikowany: 14.07.2023

  9. Episode 49 – PE Views: Will Greenwashing Rain on the UK PE Parade?

    Opublikowany: 20.06.2023

  10. Episode 48 – M&A Views: Will UK-Bound M&A Need to Come to US Terms?

    Opublikowany: 27.04.2023

  11. Episode 47 – Real Estate Realities in Europe: Expensive Money and the Power of Private Equity

    Opublikowany: 17.04.2023

  12. Episode 46 – PE Views: PE Must Strike the Right Balance With Unions

    Opublikowany: 31.03.2023

  13. Episode 45 – Will Insurtech Reach New Heights in 2023?

    Opublikowany: 8.03.2023

  14. Episode 44 – PE Views: Private Equity Looks to Share-Based Schemes to Incentivise Non-Managerial Staff

    Opublikowany: 20.01.2023

  15. Episode 43 – Energy & Infrastructure: The Drivers and Opportunities of Asia’s Digital Infrastructure Boom

    Opublikowany: 1.11.2022

  16. Episode 42 – PE Views: Has Rethinking Cannabis Sparked PE Interest?

    Opublikowany: 11.07.2022

  17. Episode 41 – PE Views: Why Do Music Deals Sound So Attractive to PE?

    Opublikowany: 9.06.2022

  18. Episode 40 – PE Views: Could PE Benefit From the Universal Adoption of “Super Senior” RCFs in Leveraged Financings?

    Opublikowany: 28.04.2022

  19. Episode 39 – New FDA Commissioner Dr. Califf: What His Appointment Means for the Regulated Industry and What to Watch for in 2022

    Opublikowany: 15.02.2022

  20. Episode 38 – PE Views: How are ESG Regulatory Reforms and Investor Focus Shaping the Market?

    Opublikowany: 14.02.2022

3 / 5

In each episode of Connected With Latham, we discuss ideas, developments, and trends shaping the global economy.

Visit the podcast's native language site